# VivoSim Labs, INC.: filings

VIVS · Nasdaq · CIK 1497253 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/vivs.md) · [Financials](/companies/vivs/financials.md) · [Filings](/companies/vivs/filings.md) · [Insiders](/companies/vivs/insiders.md)

## Reports and events: 289 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 258, 8-K 187, 10-Q 46, 3 36, CORRESP 25, SC 13G/A 21, DEFA14A 20, UPLOAD 17, 10-K 15, 424B5 15, 425 15, DEF 14A 15, EFFECT 14, S-8 12, S-1/A 9, 5 8, SC 13G 8, CT ORDER 7, 8-K/A 6, PRE 14A 6, S-1 6, 10-K/A 5, 424B3 5, S-3 5, S-8 POS 5, ARS 4, SC TO-I/A 4, 424B4 3, D 3, NT 10-K 3, POS AM 3, S-4/A 3, SCHEDULE 13G/A 3, 3/A 2, 4/A 2, 8-A12B 2, PX14A6G 2, SEC STAFF LETTER 2, 10-KT 1, 144 1, 25 1, 8-A12G 1, CERTNAS 1, CERTNYS 1, D/A 1, DEFR14A 1, DRS 1, NT 10-Q 1, PRER14A 1, RW 1, S-4 1, SCHEDULE 13G 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 20:05 ET | [8-K](/filings/0001193125-26-424061.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-424061 |
| 2026-10-06 | 20:05 ET | [8-K](/filings/0001193125-26-415542.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-415542 |
| 2026-08-21 | 20:05 ET | [8-K](/filings/0001193125-26-361085.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-26-361085 |
| 2026-08-21 | 20:02 ET | [DEF 14A](/filings/0001193125-26-361066.md) | Proxy statement, period 2026-09-30 | 0001193125-26-361066 |
| 2026-08-12 | 20:06 ET | [10-Q](/filings/0001193125-26-346820.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346820 |
| 2026-08-06 | 12:05 ET | [8-K](/filings/0001193125-26-336844.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336844 |
| 2026-07-31 | 20:16 ET | [S-1](/filings/0001193125-26-328613.md) | Registration statement | 0001193125-26-328613 |
| 2026-07-30 | 20:12 ET | [8-K](/filings/0001193125-26-326139.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-326139 |
| 2026-07-24 | 20:07 ET | [8-K](/filings/0001213900-26-081377.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-081377 |
| 2026-07-17 | 12:45 ET | [8-K](/filings/0001193125-26-306849.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-306849 |
| 2026-07-14 | 20:50 ET | [10-K](/filings/0001193125-26-303316.md) | Annual report, period 2026-03-31 | 0001193125-26-303316 |
| 2026-04-03 | 20:05 ET | [8-K](/filings/0001193125-26-142106.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-142106 |
| 2026-03-31 | 14:17 ET | [S-1/A](/filings/0001213900-26-037009.md) | Registration statement, amended | 0001213900-26-037009 |
| 2026-03-27 | 21:26 ET | [S-1](/filings/0001213900-26-035742.md) | Registration statement | 0001213900-26-035742 |
| 2026-02-11 | 21:05 ET | [10-Q](/filings/0001193125-26-046520.md) | Quarterly report, period 2025-12-31 | 0001193125-26-046520 |
| 2025-12-18 | 21:05 ET | [8-K](/filings/0001193125-25-324794.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-324794 |
| 2025-11-06 | 21:08 ET | [10-Q](/filings/0001193125-25-269483.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269483 |
| 2025-11-03 | 21:06 ET | [DEF 14A](/filings/0001193125-25-262543.md) | Proxy statement, period 2025-12-16 | 0001193125-25-262543 |
| 2025-08-14 | 12:06 ET | [8-K](/filings/0000950170-25-108447.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-108447 |
| 2025-08-12 | 20:05 ET | [10-Q](/filings/0000950170-25-107284.md) | Quarterly report, period 2025-06-30 | 0000950170-25-107284 |
| 2025-07-29 | 20:05 ET | [10-K/A](/filings/0000950170-25-099620.md) | Annual report, amended, period 2025-03-31 | 0000950170-25-099620 |
| 2025-06-05 | 20:05 ET | [10-K](/filings/0000950170-25-082312.md) | Annual report, period 2025-03-31 | 0000950170-25-082312 |
| 2025-05-06 | 12:05 ET | [8-K](/filings/0000950170-25-063979.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-063979 |
| 2025-04-24 | 12:30 ET | [8-K](/filings/0000950170-25-057685.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-057685 |
| 2025-04-23 | 12:06 ET | [8-K](/filings/0000950170-25-056974.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-056974 |
| 2025-04-02 | 12:06 ET | [8-K](/filings/0000950170-25-048888.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-048888 |
| 2025-03-27 | 12:05 ET | [8-K](/filings/0000950170-25-045740.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-045740 |
| 2025-03-26 | 12:05 ET | [8-K](/filings/0000950170-25-044801.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-044801 |
| 2025-03-21 | 12:05 ET | [8-K](/filings/0000950170-25-042903.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-042903 |
| 2025-03-19 | 12:06 ET | [8-K](/filings/0000950170-25-041749.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-041749 |
| 2025-03-06 | 13:05 ET | [8-K](/filings/0000950170-25-034181.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-034181 |
| 2025-02-25 | 13:06 ET | [8-K](/filings/0000950170-25-026097.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-026097 |
| 2025-02-19 | 14:00 ET | [10-Q](/filings/0000950170-25-022778.md) | Quarterly report, period 2024-12-31 | 0000950170-25-022778 |
| 2025-01-17 | 22:30 ET | [8-K](/filings/0000950170-25-006819.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-25-006819 |
| 2024-12-31 | 13:05 ET | [8-K](/filings/0000950170-24-141323.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-141323 |
| 2024-11-22 | 13:05 ET | [8-K](/filings/0000950170-24-129965.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-129965 |
| 2024-11-08 | 21:04 ET | [10-Q](/filings/0000950170-24-124044.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124044 |
| 2024-10-25 | 21:00 ET | [S-1](/filings/0000950170-24-117458.md) | Registration statement | 0000950170-24-117458 |
| 2024-10-07 | 20:05 ET | [DEF 14A](/filings/0000950170-24-113206.md) | Proxy statement, period 2024-10-04 | 0000950170-24-113206 |
| 2024-08-09 | 20:05 ET | [8-K](/filings/0000950170-24-094736.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-094736 |
| 2024-08-05 | 20:05 ET | [10-Q](/filings/0000950170-24-090726.md) | Quarterly report, period 2024-06-30 | 0000950170-24-090726 |
| 2024-07-26 | 20:05 ET | [10-K/A](/filings/0000950170-24-086880.md) | Annual report, amended, period 2024-03-31 | 0000950170-24-086880 |
| 2024-07-24 | 20:05 ET | [8-K](/filings/0000950170-24-086026.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0000950170-24-086026 |
| 2024-05-31 | 20:05 ET | [10-K](/filings/0000950170-24-067301.md) | Annual report, period 2024-03-31 | 0000950170-24-067301 |
| 2024-05-13 | 21:00 ET | [8-K](/filings/0000950170-24-058805.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-058805 |
| 2024-05-01 | 12:05 ET | [8-K](/filings/0000950170-24-050906.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-050906 |
| 2024-04-30 | 21:30 ET | [S-1/A](/filings/0000950170-24-050663.md) | Registration statement, amended | 0000950170-24-050663 |
| 2024-04-23 | 20:05 ET | [8-K](/filings/0000950170-24-046879.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-046879 |
| 2024-04-12 | 21:16 ET | [S-1](/filings/0000950170-24-044137.md) | Registration statement | 0000950170-24-044137 |
| 2024-02-08 | 21:05 ET | [10-Q](/filings/0000950170-24-012754.md) | Quarterly report, period 2023-12-31 | 0000950170-24-012754 |

Page 1 of 6. [Older](/companies/vivs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.